Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / 2020 - Page 56

Year: 2020

NIAID strategic plan detailed COVID-19 research priorities
COVID-19 | Life Science History

NIAID strategic plan detailed COVID-19 research priorities

On Apr. 23, 2020, a new strategic plan from the National Institute of Allergy and Infectious Diseases (NIAID),…

Read More NIAID strategic plan detailed COVID-19 research prioritiesContinue

Oxford University COVID-19 vaccine began human trial stage
COVID-19 | Therapeutics | Vaccine

Oxford University COVID-19 vaccine began human trial stage

On Apr. 23, 2020, University of Oxford researchers announced they had begun testing a COVID-19 vaccine in human…

Read More Oxford University COVID-19 vaccine began human trial stageContinue

Oxford University Government began collaboration to track Covid-19 in UK population launched
COVID-19 | Life Science History

Oxford University Government began collaboration to track Covid-19 in UK population launched

On Apr. 23, 2020, researchers from the University of Oxford are supporting a new government study to track…

Read More Oxford University Government began collaboration to track Covid-19 in UK population launchedContinue

AstraZeneca and Saint Lukeメs Mid America Heart Institute initiated phase III DARE-19 trial with Farxiga in COVID-19 patients
COVID-19 | Life Science History

AstraZeneca and Saint Lukeメs Mid America Heart Institute initiated phase III DARE-19 trial with Farxiga in COVID-19 patients

On Apr. 23, 2020, AstraZeneca and and Saint Lukeメs Mid America Heart Institute initiated a randomised, global Phase…

Read More AstraZeneca and Saint Lukeメs Mid America Heart Institute initiated phase III DARE-19 trial with Farxiga in COVID-19 patientsContinue

Oxford University and Guangdong Centre for Diseases Control and Prevention use virus genomic tracking to reveal rise and fall of COVID-19 epidemic
COVID-19 | Genomics | Life Science History

Oxford University and Guangdong Centre for Diseases Control and Prevention use virus genomic tracking to reveal rise and fall of COVID-19 epidemic

On Apr. 23, 2020, a study led by researchers at Oxford and Guangdong Centre for Diseases Control and…

Read More Oxford University and Guangdong Centre for Diseases Control and Prevention use virus genomic tracking to reveal rise and fall of COVID-19 epidemicContinue

Key nose cells identified as likely COVID-19 entry points
COVID-19 | Life Science History

Key nose cells identified as likely COVID-19 entry points

On Apr. 23, 2020, the Wellcome Sanger Institute announced that two specific cell types in the nose has…

Read More Key nose cells identified as likely COVID-19 entry pointsContinue

TGen contributed to international studies identifying cell-types susceptible to SARS-CoV-2 infection
COVID-19 | Life Science History

TGen contributed to international studies identifying cell-types susceptible to SARS-CoV-2 infection

On Apr. 23, 2020, two significant international studies involving hundreds of scientists, including a human geneticist at the…

Read More TGen contributed to international studies identifying cell-types susceptible to SARS-CoV-2 infectionContinue

CareDx and Johns Hopkins partnered on AlloSure lung surveillance for severe COVID-19 patients
Life Science History

CareDx and Johns Hopkins partnered on AlloSure lung surveillance for severe COVID-19 patients

On Apr. 23, 2020, CareDx and Johns Hopkins University announced the launch of the ALARM (AlloSure Lung Allograft…

Read More CareDx and Johns Hopkins partnered on AlloSure lung surveillance for severe COVID-19 patientsContinue

Yale launched clinical trial for drug to treat severe COVID-19 patients
COVID-19 | Life Science History

Yale launched clinical trial for drug to treat severe COVID-19 patients

On Apr. 23, 2020, Yale researchers began a clinical trial at Yale New Haven Hospital to test the…

Read More Yale launched clinical trial for drug to treat severe COVID-19 patientsContinue

ViralClear published comparative in vitro data on merimepodib and remdesivir activity against COVID-19 novel Coronavirus in F1000 research
COVID-19 | Infectious Disease | Therapeutics

ViralClear published comparative in vitro data on merimepodib and remdesivir activity against COVID-19 novel Coronavirus in F1000 research

On Apr. 23, 2020, BioSig Technologies announced that an article titled, ‘The IMPDH inhibitor merimepodib has similar antiviral…

Read More ViralClear published comparative in vitro data on merimepodib and remdesivir activity against COVID-19 novel Coronavirus in F1000 researchContinue

Catalent Biologics completed $14 million commercial packaging expansion at its Bloomington, Indiana facility
Life Science History

Catalent Biologics completed $14 million commercial packaging expansion at its Bloomington, Indiana facility

On Apr. 23, 2020, Catalent announced the completion of its $14 million expansion to increase the biologics packaging…

Read More Catalent Biologics completed $14 million commercial packaging expansion at its Bloomington, Indiana facilityContinue

Emergent BioSolutions signed agreement to be U.S. manufacturing partner for Johnson & Johnson’s lead vaccine candidate for COVID-19
COVID-19 | Pharmaceutical | Therapeutics | Vaccine

Emergent BioSolutions signed agreement to be U.S. manufacturing partner for Johnson & Johnson’s lead vaccine candidate for COVID-19

On Apr. 23, 2020, Emergent BioSolutions announced an agreement whereby Emergent will deploy its contract development and manufacturing…

Read More Emergent BioSolutions signed agreement to be U.S. manufacturing partner for Johnson & Johnson’s lead vaccine candidate for COVID-19Continue

CHF Solutions shipped first commercial orders of Aquadex SmartFlow system to Austria
Medical Device | Therapeutics

CHF Solutions shipped first commercial orders of Aquadex SmartFlow system to Austria

On Apr. 23, 2020, CHF Solutions announced that it had shipped the first commercial orders of its next…

Read More CHF Solutions shipped first commercial orders of Aquadex SmartFlow system to AustriaContinue

Mayo Clinic partnered with state of Minnesota, University of Minnesota on breakthrough COVID-19 initiative
Biotechnology | COVID-19 | Infectious Disease | Non-Profit Research | Therapeutics

Mayo Clinic partnered with state of Minnesota, University of Minnesota on breakthrough COVID-19 initiative

On Apr. 23, 2020, the Mayo Clinic, Minnesota Department of Health and University of Minnesota announced a breakthrough…

Read More Mayo Clinic partnered with state of Minnesota, University of Minnesota on breakthrough COVID-19 initiativeContinue

Johnson & Johnson announced collaboration to expand manufacturing capabilities for its COVID-19 vaccine candidate
COVID-19 | Life Science History | Vaccine

Johnson & Johnson announced collaboration to expand manufacturing capabilities for its COVID-19 vaccine candidate

On Apr. 23, 2020, Johnson & Johnson announced a collaboration between the Janssen Pharmaceutical of Johnson & Johnson…

Read More Johnson & Johnson announced collaboration to expand manufacturing capabilities for its COVID-19 vaccine candidateContinue

Brensocatib (formerly INS1007) to be studied in patients with severe COVID-19 in investigator-initiated trial
COVID-19 | Life Science History

Brensocatib (formerly INS1007) to be studied in patients with severe COVID-19 in investigator-initiated trial

On Apr. 23, 2020, Insmed announced that it will provide funding and clinical drug supply for the STOP-COVID19…

Read More Brensocatib (formerly INS1007) to be studied in patients with severe COVID-19 in investigator-initiated trialContinue

Caladrius Biosciences planned to assess CLBS119 cell therapy for repair of COVID-19 induced lung damage
COVID-19 | FDA | Life Science History

Caladrius Biosciences planned to assess CLBS119 cell therapy for repair of COVID-19 induced lung damage

On Apr. 23, 2020, Caladrius Biosciences announced the FDA has authorized its investigational new drug application for the…

Read More Caladrius Biosciences planned to assess CLBS119 cell therapy for repair of COVID-19 induced lung damageContinue

Roswell Park and Partners announced new Western New York Immunogenomic COVID-19 Study
Biotechnology | COVID-19 | Therapeutics

Roswell Park and Partners announced new Western New York Immunogenomic COVID-19 Study

On Apr. 23, 2020, Western New York healthcare and medical research leaders joined forces in an effort to…

Read More Roswell Park and Partners announced new Western New York Immunogenomic COVID-19 StudyContinue

Daxor awarded $1.1 million contract from US Department of Defense for rapid portable blood volume analyzer
Diagnostics | Medical Device

Daxor awarded $1.1 million contract from US Department of Defense for rapid portable blood volume analyzer

On Apr. 23, 2020, Daxor Corp. announced that the U.S. Department of Defense (DOD) had awarded the Company…

Read More Daxor awarded $1.1 million contract from US Department of Defense for rapid portable blood volume analyzerContinue

The USDA confirmed COVID-19 in two pet cats in New York
COVID-19 | Life Science History | USDA | Veterinary

The USDA confirmed COVID-19 in two pet cats in New York

On Apr. 22, 2020, the CDC and the USDA National Veterinary Services Laboratories announced the first confirmed cases…

Read More The USDA confirmed COVID-19 in two pet cats in New YorkContinue

LivaNova permitted to modify cardiopulmonary products’ indications for use to include ECMO therapy to address COVID-19
COVID-19 | FDA | Medical Device

LivaNova permitted to modify cardiopulmonary products’ indications for use to include ECMO therapy to address COVID-19

On Apr. 22, 2020, LivaNova announced that several of its cardiopulmonary products are now permitted to be used…

Read More LivaNova permitted to modify cardiopulmonary products’ indications for use to include ECMO therapy to address COVID-19Continue

BARDA, Tangen Biosciences partnership pursues SARS-CoV-2 diagnostic
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Medical Device

BARDA, Tangen Biosciences partnership pursues SARS-CoV-2 diagnostic

On Apr. 22, 2020, the Biomedical Advanced Research and Development Authority (BARDA) and Tangen Biosciences announced teaming up…

Read More BARDA, Tangen Biosciences partnership pursues SARS-CoV-2 diagnosticContinue

SNBL announced participation in development of a prophylactic DNA vaccine for COVID-19
COVID-19 | Life Science History | Vaccine

SNBL announced participation in development of a prophylactic DNA vaccine for COVID-19

On Apr. 20, 2020, SNBL announced their intention to participate in the development of a prophylactic DNA vaccine…

Read More SNBL announced participation in development of a prophylactic DNA vaccine for COVID-19Continue

The FDA approved new therapy for triple negative breast cancer
Biotechnology | Disease | FDA | Oncology | Therapeutics

The FDA approved new therapy for triple negative breast cancer

On Apr. 22, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy),…

Read More The FDA approved new therapy for triple negative breast cancerContinue

Quidel’s Lyra direct SARS-CoV-2 assay submitted for Emergency Use Authorization for molecular detection of COVID-19
Biotechnology | FDA

Quidel’s Lyra direct SARS-CoV-2 assay submitted for Emergency Use Authorization for molecular detection of COVID-19

On Apr. 22, 2020, Quidel announced it has applied for an Emergency Use Authorization (EUA) for the Lyraᆴ…

Read More Quidel’s Lyra direct SARS-CoV-2 assay submitted for Emergency Use Authorization for molecular detection of COVID-19Continue

Tyson Foods indefinitely suspended operations in Waterloo, Iowa
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

Tyson Foods indefinitely suspended operations in Waterloo, Iowa

On Apr. 22, 2020, Tyson Fresh Meats, the beef and pork subsidiary of Tyson Food, planned to indefinitely…

Read More Tyson Foods indefinitely suspended operations in Waterloo, IowaContinue

Researchers identified cells likely targeted by COVID-19 virus
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research | Therapeutics

Researchers identified cells likely targeted by COVID-19 virus

On Apr. 22, 2020, researchers at Massachusetts Institute of Technology (MIT); the Ragon Institute of MGH, and Harvard…

Read More Researchers identified cells likely targeted by COVID-19 virusContinue

Federal funding for rapid COVID-19 test goes to McKelvey Engineering researchers
COVID-19 | Diagnostics | Medical Device | Nanotechnology

Federal funding for rapid COVID-19 test goes to McKelvey Engineering researchers

On Apr. 22, 2020, Engineers at the McKelvey School of Engineering at Washington University in St. Louis announced…

Read More Federal funding for rapid COVID-19 test goes to McKelvey Engineering researchersContinue

LabCorp broadened availability of COVID-19 serological antibody tests to hospitals and healthcare organizations
Biotechnology | COVID-19 | Diagnostics | Medical Device

LabCorp broadened availability of COVID-19 serological antibody tests to hospitals and healthcare organizations

On Apr. 22, 2020, LabCorp announced expanded serological testing for SARS-CoV-2, the virus that causes COVID-19, to more…

Read More LabCorp broadened availability of COVID-19 serological antibody tests to hospitals and healthcare organizationsContinue

BioNTech and Pfizer announced regulatory approval from German authority to commence first clinical trial of COVID-19 vaccine candidates
COVID-19 | Life Science History | Vaccine

BioNTech and Pfizer announced regulatory approval from German authority to commence first clinical trial of COVID-19 vaccine candidates

On Apr. 22, 2020, BioNTech and Pfizer announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the…

Read More BioNTech and Pfizer announced regulatory approval from German authority to commence first clinical trial of COVID-19 vaccine candidatesContinue

Page navigation

Previous PagePrevious 1 … 54 55 56 57 58 … 76 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search